Developer of biosimilar theraputics
Issues related to improving and expanding the biosimilars marketplace through policies that will create a more even playing field for biosimilars in the overall prescription drug marketplace in the United States. Areas of focus include policies regarding patent law, public and private reimbursement and FDA interchangeability standards.
PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL